Compare HCA Health Inc (HCA) vs Morgan Stanley (MS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Morgan Stanley — how do they compare? HCA Health Inc trades at $371.96 (market cap $82.17B), while Morgan Stanley trades at $213.03 (market cap $331.60B). The key difference: Morgan Stanley is far larger — about 4× HCA Health Inc's market cap, and Morgan Stanley pays the higher dividend (2.18%). Which is the better fit depends on your goals.
| HCA | MS | |
|---|---|---|
Market Cap | $82.17B | $331.60B |
Sector | Health | Financials |
52-Week High | $545.13 | $228.42 |
52-Week Low | $334.32 | $139.09 |
Enterprise Value | $131.08B | — |
Dividend Yield | 0.84% | 2.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.
The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.
Morgan Stanley (MS) trades at $210.97, down 2.09% over the past day, with a bullish technical signal from moving averages and a consensus analyst price target of $241.36. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $3.46 surpassing estimates of $2.89. Revenue growth accelerated to $66.0 billion in 2025, up from $57.6 billion in 2024, while net income margin improved to 25.56%. Recent developments include leading Anthropic's upcoming IPO and expanding AI integration in wealth management services.
The outlook remains positive given strong earnings momentum, analyst bullishness, and strategic initiatives in high-growth areas like AI and IPO advisory. Key risks include volatile cash flows from operations, rising debt levels, and sensitivity to financial market conditions. The stock offers potential upside to analyst targets but requires monitoring of operational cash generation and macroeconomic headwinds affecting the financial sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →
